Loading...

Jack Resneck Jr., MD

TitleProfessor
SchoolUCSF School of Medicine
DepartmentDermatology
Address1701 Divisadero
San Francisco CA 94115
Phone415-353-9610
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Brown University, Providence, RIBA06/1992Public Policy
    UCSF School of Medicine, San Francisco, CAMD06/1997Medicine
    UCSF School of Medicine Dept. of Medicine06/1998Internship in Internal Medicine
    UCSF School of Medicine Dept. of Dermatology06/2001Residency in Dermatology
    UCSF Philip R. Lee Institute for Health Policy Studies06/2003Fellowship in Health Policy

    Collapse Overview 
    Collapse Overview
    Dr. Resneck is Professor and Vice-Chair of the UCSF Department of Dermatology, and holds a joint appointment as a core faculty member at the Philip R. Lee Institute for Health Policy Studies. He also directs the dermatology faculty practice clinics at UCSF where he previously ran the dermatology residency training program.

    Passionate about advocacy for physicians and patients, Dr. Resneck has held several leadership positions in organized medicine. He was elected to the American Medical Association (AMA) Board of Trustees in 2014, and now serves as Chair-Elect of the AMA Board. He previously served as an elected director on the Board of the American Academy of Dermatology (AAD). The AAD has awarded him several presidential citations, as well as its prestigious Clarence S. Livingood Award and Lectureship. He is a past-president of the California Society for Dermatology, and serves on the Editorial Board of the Journal of the American Academy of Dermatology.

    His health policy research examines physician workforce issues, access to outpatient specialty care, the future of academic medicine, the impact of non-physician clinicians, health system reform, the medical liability system, and telehealth. He has authored numerous articles in scientific journals, testified before Congress, been interviewed by major media outlets, and is a sought-after speaker on policy issues.

    Dr. Resneck is deeply engaged in modernizing medical education and teaching the next generation of physicians, and recently chaired the committee that oversees UCSF’s innovative medical school curriculum. He has a busy clinical practice and cares for patients with a wide range of skin diseases.

    Dr. Resneck's community service endeavors have focused on providing care to patients with HIV-infection and skin disease in East Africa and fundraising for dermatology research. He was also instrumental in passing California’s first-in-the-nation complete ban on indoor tanning by children under the age of 18.

    Dr. Resneck received his B.A. in public policy from Brown University and his M.D. from the University of California, San Francisco. His internship in internal medicine, residency in dermatology, and health policy fellowship were also at UCSF.


    Collapse ORNG Applications 
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Lim HW, Collins SA, Resneck JS, Bolognia JL, Hodge JA, Rohrer TA, Van Beek MJ, Margolis DJ, Sober AJ, Weinstock MA, Nerenz DR, Smith Begolka W, Moyano JV. The burden of skin disease in the United States. J Am Acad Dermatol. 2017 Feb 27. PMID: 28259441.
      View in: PubMed
    2. Resneck JS. Transparency Associated With Interactions Between Industry and Physicians: Deficits in Accuracy and Consistency of Public Data Releases. JAMA Dermatol. 2016 Dec 01; 152(12):1303-1304. PMID: 27706480.
      View in: PubMed
    3. Resneck JS, Abrouk M, Steuer M, Tam A, Yen A, Lee I, Kovarik CL, Edison KE. Choice, Transparency, Coordination, and Quality Among Direct-to-Consumer Telemedicine Websites and Apps Treating Skin Disease. JAMA Dermatol. 2016 Jul 01; 152(7):768-75. PMID: 27180232.
      View in: PubMed
    4. Cidre Serrano W, Chren MM, Resneck JS, Aji NN, Pagoto S, Linos E. Online Advertising for Cancer Prevention: Google Ads and Tanning Beds. JAMA Dermatol. 2016 Jan 1; 152(1):101-2. PMID: 26444220.
      View in: PubMed
    5. Linos E, VanBeek M, Resneck JS. Radiation Oncologist Concerns About Increased Electronic Brachytherapy Use for Skin Cancer--Reply. JAMA Dermatol. 2015 Sep; 151(9):1037. PMID: 26177163.
      View in: PubMed
    6. Linos E, VanBeek M, Resneck JS. A Sudden and Concerning Increase in the Use of Electronic Brachytherapy for Skin Cancer. JAMA Dermatol. 2015 Jul; 151(7):699-700. PMID: 25785818.
      View in: PubMed
    7. Resneck JS, VanBeek M. What dermatology still needs to create meaningful patient outcome measurements. JAMA Dermatol. 2015 Apr; 151(4):371-2. PMID: 25549325.
      View in: PubMed
    8. Resneck JS, Quiggle A, Liu M, Brewster DW. The accuracy of dermatology network physician directories posted by Medicare Advantage health plans in an era of narrow networks. JAMA Dermatol. 2014 Dec; 150(12):1290-7. PMID: 25354035.
      View in: PubMed
    9. Wehner MR, Chren MM, Shive ML, Resneck JS, Pagoto S, Seidenberg AB, Linos E. Twitter: an opportunity for public health campaigns. Lancet. 2014 Jul 12; 384(9938):131-2. PMID: 25016994.
      View in: PubMed
    10. Grewal SK, Haas AF, Pletcher MJ, Resneck JS. Compliance by California tanning facilities with the nation's first statewide ban on use before the age of 18 years. J Am Acad Dermatol. 2013 Dec; 69(6):883-889.e4. PMID: 24120564.
      View in: PubMed
    11. Lim HW, Resneck JS, Fischoff R. Research agenda consensus conference. J Am Acad Dermatol. 2013 Aug; 69(2):294. PMID: 23643342.
      View in: PubMed
    12. Resneck JS. Dermatology workforce policy then and now: reflections on Dr Peyton Weary's 1979 manuscript. J Am Acad Dermatol. 2013 Feb; 68(2):338-9. PMID: 23317972.
      View in: PubMed
    13. Resneck JS, Kostecki J. An analysis of dermatologist migration patterns after residency training. Arch Dermatol. 2011 Sep; 147(9):1065-70. PMID: 21931044.
      View in: PubMed
    14. Resneck JS. An analysis of health system reform for dermatologists: elements and implications of the Patient Protection and Affordable Care Act. J Am Acad Dermatol. 2010 Oct; 63(4):706-15. PMID: 20708300.
      View in: PubMed
    15. Resneck JS, VanBeek M. Shared medical appointments: will changes in health care delivery and financing promote increased use of nonphysician clinicians in dermatology patient counseling? Arch Dermatol. 2010 Apr; 146(4):434-6. PMID: 20404236.
      View in: PubMed
    16. Resneck JS, Vanbeek M. Individual drug sampling does not supplant the need for head-to-head trials in dermatology. J Am Acad Dermatol. 2010 Jun; 62(6):1062-3. PMID: 20172624.
      View in: PubMed
    17. Elston DM, Taylor JS, Coldiron B, Hood AF, Read SI, Resneck JS, Kirsner RS, Maize JC, Sullivan S, Laskas J, Hanke CW. Patient safety: Part I. Patient safety and the dermatologist. J Am Acad Dermatol. 2009 Aug; 61(2):179-90; quiz 191. PMID: 19615535.
      View in: PubMed
    18. Feldman SR, Resneck JS. Commentary: The relative ease of obtaining a dermatologic appointment in Boston: how methods drive results. J Am Acad Dermatol. 2009 Jun; 60(6):949-50. PMID: 19467367.
      View in: PubMed
    19. Feramisco JD, Leitenberger JJ, Redfern SI, Bian A, Xie XJ, Resneck JS. A gender gap in the dermatology literature? Cross-sectional analysis of manuscript authorship trends in dermatology journals during 3 decades. J Am Acad Dermatol. 2009 Jan; 60(1):63-9. PMID: 19103359.
      View in: PubMed
    20. Craiglow BG, Resneck JS, Lucky AW, Sidbury R, Yan AC, Resnick SD, Antaya RJ. Pediatric dermatology workforce shortage: perspectives from academia. J Am Acad Dermatol. 2008 Dec; 59(6):986-9. PMID: 18835061.
      View in: PubMed
    21. Kimball AB, Resneck JS. The US dermatology workforce: a specialty remains in shortage. J Am Acad Dermatol. 2008 Nov; 59(5):741-5. PMID: 18723242.
      View in: PubMed
    22. Resneck JS, Kimball AB. Who else is providing care in dermatology practices? Trends in the use of nonphysician clinicians. J Am Acad Dermatol. 2008 Feb; 58(2):211-6. PMID: 18222319.
      View in: PubMed
    23. Resneck JS, Lipton S, Pletcher MJ. Short wait times for patients seeking cosmetic botulinum toxin appointments with dermatologists. J Am Acad Dermatol. 2007 Dec; 57(6):985-9. PMID: 17720277.
      View in: PubMed
    24. Resneck JS, Isenstein A, Kimball AB. Few Medicaid and uninsured patients are accessing dermatologists. J Am Acad Dermatol. 2006 Dec; 55(6):1084-8. PMID: 17097404.
      View in: PubMed
    25. Resneck JS. The influence of controllable lifestyle on medical student specialty choice. Virtual Mentor. 2006; 8(8):529-32. PMID: 23234693.
      View in: PubMed
    26. Tsang MW, Resneck JS. Even patients with changing moles face long dermatology appointment wait-times: a study of simulated patient calls to dermatologists. J Am Acad Dermatol. 2006 Jul; 55(1):54-8. PMID: 16781292.
      View in: PubMed
    27. Resneck JS. Trends in malpractice premiums for dermatologists: results of a national survey. Arch Dermatol. 2006 Mar; 142(3):337-40. PMID: 16549709.
      View in: PubMed
    28. Resneck JS, Kimball AB. Dinners with Irwin: mentorship, the work force, and the future of academic dermatology. J Invest Dermatol. 2006 Mar; 126(3):529-30. PMID: 16482186.
      View in: PubMed
    29. Resneck JS, Tierney EP, Kimball AB. Challenges facing academic dermatology: survey data on the faculty workforce. J Am Acad Dermatol. 2006 Feb; 54(2):211-6. PMID: 16443049.
      View in: PubMed
    30. Jacobson CC, Resneck JS, Kimball AB. Generational differences in practice patterns of dermatologists in the United States: implications for workforce planning. Arch Dermatol. 2004 Dec; 140(12):1477-82. PMID: 15611425.
      View in: PubMed
    31. Resneck JS, Van Beek M, Furmanski L, Oyugi J, LeBoit PE, Katabira E, Kambugu F, Maurer T, Berger T, Pletcher MJ, Machtinger EL. Etiology of pruritic papular eruption with HIV infection in Uganda. JAMA. 2004 Dec 1; 292(21):2614-21. PMID: 15572719.
      View in: PubMed
    32. Resneck J, Luft H. How health policy and health services researchers are compensated: analysis of a nationwide salary survey. Med Care Res Rev. 2004 Sep; 61(3):392-408. PMID: 15358973.
      View in: PubMed
    33. Resneck J, Pletcher MJ, Lozano N. Medicare, Medicaid, and access to dermatologists: the effect of patient insurance on appointment access and wait times. J Am Acad Dermatol. 2004 Jan; 50(1):85-92. PMID: 14699371.
      View in: PubMed
    34. Resneck J, Kimball AB. The dermatology workforce shortage. J Am Acad Dermatol. 2004 Jan; 50(1):50-4. PMID: 14699364.
      View in: PubMed
    35. Maize JC, Resneck JS, Shapiro PE, McCalmont TH, LeBoit PE. Ducking stray "magic bullets": a Melan-A alert. Am J Dermatopathol. 2003 Apr; 25(2):162-5. PMID: 12652201.
      View in: PubMed
    36. Resneck J. Drug samples: friend or foe? J Drugs Dermatol. 2002 Sep; 1(2):124. PMID: 12847734.
      View in: PubMed
    37. Resneck J. Too few or too many dermatologists? Difficulties in assessing optimal workforce size. Arch Dermatol. 2001 Oct; 137(10):1295-301. PMID: 11594852.
      View in: PubMed
    Jack's Networks
    Concepts
    Derived automatically from this person's publications.
    See all (137) concept(s)
    _
    Co-Authors
    People in Profiles who have published with this person.
    See all (7) people
    _
    Related Authors
    People who share related concepts with this person.
    See all (60) people
    _
    Back to TOP